ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Company Announcement
Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325.
Announcement as on 23 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch
Announcement as on 16 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Compet
Announcement as on 04 March 2026

Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler
Glenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step in strengthening the company's respiratory offerings in the US market. The product is set for distribution starting Ma
Announcement as on 04 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP,
Announcement as on 27 February 2026

Announcements by Glenmark Pharmaceuticals Limited first page | Next page | Prev page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2369.7
  • 12Day Average: 2303.73
  • 20Day Average: 2237.77
  • 50Day Average: 2164.73
  • 100Day Average: 2078.55
  • 150Day Average: 2019.98
  • 200Day Average: 2030.59

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2313.38, 2245.81, 49.55
Indicator MACD is in positive zone

Indicator ADX (14)

43.1, 33.34, 13.26
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Thu Apr 2026 2406.30 2385.60 to 2455.90 -0.31% 1.14 times
29 Wed Apr 2026 2413.90 2403.70 to 2474.00 0.42% 0.89 times
28 Tue Apr 2026 2403.70 2327.30 to 2427.40 3.38% 2.21 times
27 Mon Apr 2026 2325.10 2290.90 to 2339.90 1.11% 0.67 times
24 Fri Apr 2026 2299.50 2283.20 to 2372.80 -1.52% 1.21 times
23 Thu Apr 2026 2335.00 2212.10 to 2359.40 4.24% 2.45 times
22 Wed Apr 2026 2240.00 2204.80 to 2247.00 0.31% 0.47 times
21 Tue Apr 2026 2233.10 2215.20 to 2245.00 0.11% 0.37 times
20 Mon Apr 2026 2230.70 2210.50 to 2250.50 -0.84% 0.59 times
17 Fri Apr 2026 2249.50 2240.90 to 2274.90 0% 0.53 times
16 Thu Apr 2026 2249.50 2228.60 to 2273.80 -0.39% 0.63 times
15 Wed Apr 2026 2258.40 2205.00 to 2265.00 2.98% 0.89 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top